Details for New Drug Application (NDA): 020118
NDA 020118 describes SUPRANE, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from two suppliers. Additional details are available on the SUPRANE profile page.
The generic ingredient in SUPRANE is desflurane. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the desflurane profile page.
The generic ingredient in SUPRANE is desflurane. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the desflurane profile page.
Summary for 020118
| Tradename: | SUPRANE |
| Applicant: | Baxter Hlthcare |
| Ingredient: | desflurane |
| Patents: | 0 |
Pharmacology for NDA: 020118
| Physiological Effect | General Anesthesia |
Suppliers and Packaging for NDA: 020118
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SUPRANE | desflurane | LIQUID;INHALATION | 020118 | NDA | Henry Schein, Inc. | 0404-9961 | 0404-9961-25 | 1 BOTTLE in 1 BAG (0404-9961-25) / 240 mL in 1 BOTTLE |
| SUPRANE | desflurane | LIQUID;INHALATION | 020118 | NDA | Baxter Healthcare Corporation | 10019-641 | 10019-641-34 | 6 BOTTLE in 1 CARTON (10019-641-34) / 240 mL in 1 BOTTLE (10019-641-64) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | LIQUID;INHALATION | Strength | 100% | ||||
| Approval Date: | Sep 18, 1992 | TE: | AN | RLD: | Yes | ||||
Complete Access Available with Subscription
